Paper39680334
Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities.
Askarizadeh F and 3 others. Pharmacol Rep, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities. Papers, record 39680334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39680334
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| CD40 Antigens | Major topic |
| CD40 Ligand | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Humans | |
| Signal Transduction | |
| Animals | |
| Inflammation | |
| Cardiovascular Diseases | |
| Autoimmune Diseases |
Source PubMed
References294
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15089818 | Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/15089818 | PubMed |
| 2 | 15993711 | Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains. | Hum Immunol | 2005 | https://conductscience.org/library/papers/15993711 | PubMed |
| 3 | 17482516 | Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction. | Clin Immunol | 2007 | https://conductscience.org/library/papers/17482516 | PubMed |
| 4 | 16387846 | Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. | J Leukoc Biol | 2006 | https://conductscience.org/library/papers/16387846 | PubMed |
| 5 | 25970700 | A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. | Sci Rep | 2015 | https://conductscience.org/library/papers/25970700 | PubMed |
| 6 | 37732056 | The effects of statins on the function and differentiation of blood cells. | Arch Med Sci | 2023 | https://conductscience.org/library/papers/37732056 | PubMed |
| 7 | 33656763 | The role of statins in the differentiation and function of bone cells. | Eur J Clin Invest | 2021 | https://conductscience.org/library/papers/33656763 | PubMed |
| 8 | 27498397 | Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. | Atherosclerosis | 2016 | https://conductscience.org/library/papers/27498397 | PubMed |
| 9 | 33511728 | Effects of statins on mitochondrial pathways. | J Cachexia Sarcopenia Muscle | 2021 | https://conductscience.org/library/papers/33511728 | PubMed |
| 10 | 26632869 | The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials. | Thromb Haemost | 2016 | https://conductscience.org/library/papers/26632869 | PubMed |
| 11 | 21207250 | Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. | Lipids | 2011 | https://conductscience.org/library/papers/21207250 | PubMed |
| 12 | 26017749 | Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials. | Thromb Haemost | 2015 | https://conductscience.org/library/papers/26017749 | PubMed |
| 13 | 14499877 | Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. | Cardiovasc Res | 2003 | https://conductscience.org/library/papers/14499877 | PubMed |
| 14 | 23017371 | Statins and other agents for vascular inflammation. | J Vasc Surg | 2012 | https://conductscience.org/library/papers/23017371 | PubMed |
| 15 | 11701455 | Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. | Arterioscler Thromb Vasc Biol | 2001 | https://conductscience.org/library/papers/11701455 | PubMed |
| 16 | 11100127 | Statins as a newly recognized type of immunomodulator. | Nat Med | 2000 | https://conductscience.org/library/papers/11100127 | PubMed |
| 17 | 30120976 | Effect of statins on toll-like receptors: a new insight to pleiotropic effects. | Pharmacol Res | 2018 | https://conductscience.org/library/papers/30120976 | PubMed |
| 18 | 27010807 | The "Rise-Peak-Fall" Pattern of Time Dependency of the Cardiovascular Pleiotropic Effects of Treatment With Low-dose Atorvastatin, Losartan, and a Combination Thereof in Rats. | J Cardiovasc Pharmacol | 2016 | https://conductscience.org/library/papers/27010807 | PubMed |
| 19 | 15173059 | Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? | Circulation | 2004 | https://conductscience.org/library/papers/15173059 | PubMed |
| 20 | 27120457 | Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway. | PLoS One | 2016 | https://conductscience.org/library/papers/27120457 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41676279 | The role of CD40/CD40L signaling in vascular inflammation and aneurysm progression: a systematic review and evidence synthesis. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/41676279 | PubMed |
| 41231308 | Statins as Modulators of Epithelial to Mesenchymal Transition in Cardiovascular-Kidney-Metabolic Syndrome: a Comprehensive Review of Mechanisms and Therapeutic Implications. | Curr Atheroscler Rep | 2025 | https://conductscience.org/library/papers/41231308 | PubMed |
| 41114911 | Integrative multi-omics and causal inference reveal periodontal ligament cell-macrophage crosstalk under orthodontic force. | Prog Orthod | 2025 | https://conductscience.org/library/papers/41114911 | PubMed |
| 41042403 | Overlapping risk factors and pathogenic mechanisms in lung cancer and cardiovascular disease. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41042403 | PubMed |
| 41002646 | Sjogren's Disease and Elevated Cardiovascular Risk: Mechanisms and Treatment. | J Cardiovasc Dev Dis | 2025 | https://conductscience.org/library/papers/41002646 | PubMed |
| 40427505 | Understanding the Role of Adipokines in Cardiometabolic Dysfunction: A Review of Current Knowledge. | Biomolecules | 2025 | https://conductscience.org/library/papers/40427505 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD40 | 958 | PubTator's text mining | https://conductscience.org/library/genes/958 | NCBI Gene |
| CD40LG | 959 | PubTator's text mining | https://conductscience.org/library/genes/959 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39680334
GET https://conductscience.org/api/papers/v1/39680334/references?page=2